“The Dysregulation of Mir-21 and Mir-143 As a Clinical Marker for Cancer Stem Cells in Tissue Samples of Iraqi Male Patients With Gastrointestinal Sarcoma”. 2022. Journal of Pharmaceutical Negative Results 13 (3): 20-25. https://doi.org/10.47750/pnr.2022.13.03.004.